0001012975-20-000580.txt : 20200625
0001012975-20-000580.hdr.sgml : 20200625
20200625192116
ACCESSION NUMBER: 0001012975-20-000580
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I, L.P.
CENTRAL INDEX KEY: 0001695076
STATE OF INCORPORATION: E9
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39343
FILM NUMBER: 20990570
BUSINESS ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (345) 949 1040
MAIL ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
FORMER NAME:
FORMER CONFORMED NAME: Pivotal Venture Partners Fund I, L.P.
DATE OF NAME CHANGE: 20170118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pivotal bioVenture Partners Fund I G.P., L.P.
CENTRAL INDEX KEY: 0001752862
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39343
FILM NUMBER: 20990571
BUSINESS ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 697-1002
MAIL ADDRESS:
STREET 1: 501 SECOND STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akouos, Inc.
CENTRAL INDEX KEY: 0001722271
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 857-245-5715
MAIL ADDRESS:
STREET 1: 645 SUMMER STREET, SUITE 200
CITY: BOSTON
STATE: MA
ZIP: 02210
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2020-06-25
0
0001722271
Akouos, Inc.
AKUS
0001695076
Pivotal bioVenture Partners Fund I, L.P.
501 SECOND STREET, SUITE 200
SAN FRANCISCO
CA
94107
0
0
1
0
0001752862
Pivotal bioVenture Partners Fund I G.P., L.P.
501 SECOND STREET, SUITE 200
SAN FRANCISCO
CA
94107
0
0
1
0
Series B Preferred Stock
Common Stock
1499971
I
See footnote
The Series B Preferred Stock is convertible into Common Stock on a 21.073-for-1 basis into the number of shares of Common Stock as shown in Column 3 without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P., or Pivotal GP. Robert Hopfner, Vincent Cheung, Peter Bisgaard, and Heather Preston are the managing partners of Pivotal and may be deemed to have shared voting and dispositive power over the shares owned by Pivotal.
/s/ Heather Preston, MD - for Pivotal bioVenture Partners Fund I, L.P., as Managing Partner
2020-06-25
/s/ Heather Preston, MD - for Pivotal bioVenture Partners Fund I G.P., L.P., as Managing Partner
2020-06-25